Literature DB >> 9835281

Use of a two-compartment model to assess the pharmacokinetics of human ethanol metabolism.

M D Levitt1, D G Levitt.   

Abstract

The relationship between blood ethanol concentration and hepatic ethanol metabolism commonly is calculated using the Michaelis-Menten equation and a one-compartment model that assumes equality of blood and hepatic ethanol concentrations. However, at low blood concentrations, most of the ethanol arriving at the liver is metabolized, and hepatic ethanol concentrations may fall far below that of the entering blood. We have developed a two-compartment model of ethanol metabolism that accounts for the fall in ethanol concentration that may occur as blood traverses the liver and used this model to make predictions concerning ethanol metabolism at various blood ethanol concentrations. The two-compartment model predicts that near-complete saturation will occur more abruptly and at a lower blood concentration (approximately 3 mM) than is the case with the one-compartment model. Thus, the two-compartment model predicts a near-constant ethanol elimination rate for blood ethanol concentrations above 3 mM (as commonly observed in human subjects), whereas the one-compartment model predicts an increasing elimination rate over the range of concentrations observed in experimental studies. In agreement with observed data, the two-compartment model predicts that first-pass metabolism should be extremely sensitive to the rate of ethanol absorption. Application of this model to previously published data indicated that, when absorption was slowed via concomitant food ingestion, first-pass metabolism accounts for approximately 50% and 10% of ethanol dosages of 0.15 g/kg and 0.3 g/kg, respectively. When ingested without food, there is negligible first-pass metabolism of even very small ethanol dosages (0.15 g/kg). These findings suggest that first-pass metabolism is an unimportant determinant of the blood ethanol response to ingestion of potentially inebriating doses of ethanol.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835281

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

1.  Feasibility of transdermal ethanol sensing for the detection of intoxicated drivers.

Authors:  Gregory D Webster; Hampton C Gabler
Journal:  Annu Proc Assoc Adv Automot Med       Date:  2007

Review 2.  Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.

Authors:  Ake Norberg; A Wayne Jones; Robert G Hahn; Johan L Gabrielsson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  Ethanol pharmacokinetics in neonates and infants.

Authors:  Elizabeth Marek; Walter K Kraft
Journal:  Curr Ther Res Clin Exp       Date:  2014-10-22

4.  In vivo protection against strychnine toxicity in mice by the glycine receptor agonist ivermectin.

Authors:  Ahmed Maher; Rasha Radwan; Hans-Georg Breitinger
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

5.  Alcohol and medication interactions.

Authors:  R Weathermon; D W Crabb
Journal:  Alcohol Res Health       Date:  1999

6.  Effects of alcohol-induced increase in CYP2E1 content in human liver microsomes on the activity and cooperativity of CYP3A4.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Marc A Maldonado; Armina Abbasi; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Arch Biochem Biophys       Date:  2020-11-13       Impact factor: 4.013

7.  PKQuest: measurement of intestinal absorption and first pass metabolism - application to human ethanol pharmacokinetics.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2002-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.